Eisenmenger syndrome: Towards identifying the risk factors for death

European Heart Journal

Volumn 27, Issue 14, 2006, Pages 1644-1645

  Sreeram, Narayanswami ^a  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIAC PATIENT; CASE CONTROL STUDY; DEATH; DISEASE CLASSIFICATION; EDITORIAL; EISENMENGER COMPLEX; ELECTROCARDIOGRAM; HEART FAILURE; HEART TRANSPLANTATION; HOLTER MONITORING; HUMAN; LUNG TRANSPLANTATION; PREDICTION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SURVIVAL;

CAUSE OF DEATH; DEATH, SUDDEN, CARDIAC; EISENMENGER COMPLEX; HUMANS; RISK FACTORS; SURVIVAL RATE;

EID: 33745786277     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehi823     Document Type: Editorial

References (10)

1. Wood P. The Eisenmenger syndrome or pulmonary hypertension with reversed central shunt (The Croonian Lectures). Br Med J 1958;46:755-762.
2. Cantor WJ, Harrison DA, Moussadji JS, Connelly MS, Webb GD, Liu P, McLaughlin PR, Siu SC. Determinants of survival and length of survival in adults with Eisenmenger syndrome. Am J Cardiol 1999;84:677-681.
3. Diller G-P, Dimopoulos K, Broberg CS, Kaya MG, Naghotra US, Uebing A, Harries C, Goktekin O, Gibbs JSR, Gatzoulis MA. Presentation, survival prospects and predictors of death in Eisenmenger syndrome: a combined retrospective and case-control study. Eur Heart J 2006;27:1737-1742. First published on June 22, 2006, doi:10.1093/eurheartj/ehl116.
4. Daliento L, Somerville J, Presbitero P, Menti L, Brach-Prever S, Rizzoli G, Stone S. Eisenmenger syndrome. Factors relating to deterioration and death. Eur Heart J 1998;19:1845-1855.
5. Saha A, Balakrishnan KG, Jaiswal PK, Venkitachalam CG, Tharakan J, Titus T, Kutty R. Prognosis for patients with Eisenmenger syndrome of various etiology. Int J Cardiol 1994;45:199-207.
6. Corone S, Davido A, Lang T, Corone P. Outcome of patients with Eisenmenger syndrome. Apropos of 62 cases followed up for an average of 16 years. Arch Mal Coeur Vaiss 1992;85:521-526.
7. Maron BJ, Shirani S, Poliac LC, Mathenge R, Roberts WC, Mueller FO. Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles. JAMA 1996;276:199-204.
8. Kammeraad JA, van Deurzen CH, Sreeram N, Bink-Boelkens MT, Ottenkamp J, Helbing WA, Lam J, Sobotka-Plojhar MA, Daniels O, Balaji S. Predictors of sudden cardiac death after Mustard or Senning repair for transposition of the great arteries. J Am Coll Cardiol 2004;44:1095-1102.
9. Post MC, Janssens S, Van de Werf F, Budts W. Responsiveness to inhaled nitric oxide is a predictor for mid-term survival in adult patients with congenital heart defects and pulmonary arterial hypertension. Eur Heart J 2004;25:1651-1656.
10. Galie N, Beghetti M, Gatzoulis M, Granton K, Berger R, Lauer A, Chiossi E, Landzberg M. BREATHE-5: Bosentan improves hemodynamics and exercise capacity in the first randomized placebo controlled trial in Eisenmenger physiology. (Abstract). Chest 2005;128:4965.